We are live on ! Find out more
P

Pitcairn Portfolio holdings

AUM $1.27B
1-Year Est. Return 23.64%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$833M
AUM Growth
+$7.36M
Cap. Flow
-$24.9M
Cap. Flow %
-2.99%
Top 10 Hldgs %
52.45%
Holding
520
New
34
Increased
100
Reduced
321
Closed
48

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$3.57M
2
INTU icon
Intuit
INTU
+$2.04M
3
CDNS icon
Cadence Design Systems
CDNS
+$1.21M
4
GILD icon
Gilead Sciences
GILD
+$1.12M
5
STLD icon
Steel Dynamics
STLD
+$778K

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.59%
2 Financials 10.12%
3 Technology 8.57%
4 Healthcare 7.38%
5 Consumer Discretionary 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNC icon
126
Lincoln National
LNC
$8B
$929K 0.11%
13,761
-511
-4% -$33.8K
LOW icon
127
Lowe's Companies
LOW
$114B
$921K 0.11%
11,874
-423
-3% -$34.6K
CNC icon
128
Centene
CNC
$33.4B
$919K 0.11%
23,028
+2,154
+10% +$81.3K
CSCO icon
129
Cisco
CSCO
$442B
$911K 0.11%
29,089
-15,683
-35% -$511K
AGN
130
DELISTED
Allergan plc
AGN
$904K 0.11%
3,717
+27
+0.7% +$6.34K
DSI icon
131
iShares MSCI KLD 400 Social ETF
DSI
$5.29B
$901K 0.11%
20,182
-388
-2% -$17.2K
BMY icon
132
Bristol-Myers Squibb
BMY
$124B
$893K 0.11%
16,023
-6,339
-28% -$345K
C icon
133
Citigroup
C
$223B
$883K 0.11%
13,200
+1,101
+9% +$67.5K
SNA icon
134
Snap-on
SNA
$20.9B
$882K 0.11%
5,581
-94
-2% -$15.4K
ALXN
135
DELISTED
Alexion Pharmaceuticals
ALXN
$876K 0.11%
7,202
-13,229
-65% -$1.54M
NDAQ icon
136
Nasdaq
NDAQ
$51B
$860K 0.1%
36,105
-1,320
-4% -$30.3K
VZ icon
137
Verizon
VZ
$183B
$860K 0.1%
19,247
-8,590
-31% -$400K
IWF icon
138
iShares Russell 1000 Growth ETF
IWF
$125B
$849K 0.1%
28,532
-4,236
-13% -$124K
ESRX
139
DELISTED
Express Scripts Holding Company
ESRX
$842K 0.1%
13,183
+79
+0.6% +$4.96K
AAL icon
140
American Airlines Group
AAL
$10.1B
$839K 0.1%
16,671
-9,424
-36% -$438K
KHC icon
141
Kraft Heinz
KHC
$30.6B
$837K 0.1%
9,776
-116
-1% -$10.5K
IP icon
142
International Paper
IP
$19.2B
$835K 0.1%
15,588
-191
-1% -$9.65K
SCHW
143
Charles Schwab
SCHW
$174B
$833K 0.1%
19,391
-110
-0.6% -$4.4K
MTN icon
144
Vail Resorts
MTN
$5.25B
$832K 0.1%
4,103
-313
-7% -$63.1K
WDC icon
145
Western Digital
WDC
$189B
$830K 0.1%
12,394
-274
-2% -$18.2K
MNST icon
146
Monster Beverage
MNST
$92.4B
$825K 0.1%
33,208
-226
-0.7% -$5.44K
MON
147
DELISTED
Monsanto Co
MON
$824K 0.1%
6,963
-64
-0.9% -$7.47K
PHM icon
148
Pultegroup
PHM
$23.7B
$823K 0.1%
33,523
-262
-0.8% -$6.12K
SLB icon
149
SLB Ltd
SLB
$69.7B
$823K 0.1%
12,493
-7,267
-37% -$521K
AMN icon
150
AMN Healthcare
AMN
$1.33B
$813K 0.1%
20,812
+27
+0.1% +$1.03K

Similar funds

Pitcairn's Q2 2017 Portfolio in Review

As of Q2 2017, Pitcairn held 520 positions worth $833M, up 0.89% from $825M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pitcairn's Q2 2017 filing shows 34 new, 100 increased, 321 reduced and 48 closed positions. Its largest new stake was Zoetis: 60,519 shares worth $3.77M. The largest sale was LyondellBasell Industries, an estimated $3.05M.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

  • Pitcairn's largest Q2 2017 buy was Zoetis: 60,519 shares worth $3.77M.
  • Pitcairn added most to Intuit in Q2 2017, an estimated $2.04M increase.
  • Pitcairn's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $1.54M.
  • Pitcairn fully exited LyondellBasell Industries in Q2 2017, selling an estimated $3.05M.
  • Pitcairn's ten largest holdings make up 52% of its $833M portfolio in Q2 2017.
  • Pitcairn opened 34 new positions and closed 48 in Q2 2017.
  • Pitcairn's portfolio value rose 0.89% quarter-over-quarter to $833M.

Based on Pitcairn's 13F filing for Q2 2017, filed 2 Aug 2017.